Acousort

Acousort Equity

The The Equity of Acousort (ACOU.ST) as of Oct 23, 2026 is 16.30 M SEK. In the previous year, The Equity was 8.46 M SEK — a change of 92.61% (higher).

Equity

16.30 MSEK

YoY

92.61%

Last updated:

In 2025, Acousort's equity was 16.30 M SEK, a 92.61% increase from the 8.46 M SEK equity in the previous year.

The Acousort Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
15.58 M SEK
Jan 1, 2019
5.92 M SEK
Jan 1, 2020
9.59 M SEK
Jan 1, 2021
33.02 M SEK
Jan 1, 2022
20.11 M SEK
Jan 1, 2023
24.14 M SEK
Jan 1, 2024
8.46 M SEK
Jan 1, 2025
16.30 M SEK
The Acousort Equity history
YEAREquityYoY
16.30 MSEK+92.61%
8.46 MSEK-64.93%
24.14 MSEK+19.99%
20.11 MSEK-39.09%
33.02 MSEK+244.27%
9.59 MSEK+61.97%
5.92 MSEK-61.99%
15.58 MSEK+301.21%
3.88 MSEK-60.99%
9.96 MSEK+12,560.56%
78,630.00SEK-79.11%
376,479.00SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acousort Stock analysis

What does Acousort do? AcouSort AB develops and sells standalone laboratory products like AcouWash and AcouTrap for cell, bacteria, and extracellular vesicle research, focusing on separation, washing, and enrichment using ultrasound. The company also provides integrated original equipment manufacturer (OEM) solutions and offers custom-developed acoustophoresis applications. Its target customers include research and diagnostic institutions seeking advanced cell separation technologies. The firm generates revenue through the sale of its proprietary laboratory equipment and OEM solutions, with products such as AcouWash and AcouTrap targeting cell, bacteria, and extracellular vesicle research applications. AcouSort AB develops bioanalytical and clinical applications based on acoustophoresis, which are sold to research and diagnostic markets. The company’s offerings are designed for scientific and medical research environments requiring precise biological particle separation. Acousort is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Acousort's Equity

Acousort's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Acousort's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Acousort's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Acousort's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Acousort’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Acousort stock

The Equity of Acousort is 16.30 M SEK in 2025.

The Equity of Acousort changed from 8.46 M SEK to 16.30 M SEK, representing a 92.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Acousort since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Acousort historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Acousort

All Key Metrics — Acousort